vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and POTLATCHDELTIC CORP (PCH). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $314.2M, roughly 1.6× POTLATCHDELTIC CORP). POTLATCHDELTIC CORP runs the higher net margin — 8.2% vs 6.8%, a 1.4% gap on every dollar of revenue. On growth, POTLATCHDELTIC CORP posted the faster year-over-year revenue change (23.1% vs -1.7%). Over the past eight quarters, POTLATCHDELTIC CORP's revenue compounded faster (11.1% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
POTLATCHDELTIC CORPPCHEarnings & Financial Report
PotlatchDeltic Corporation is an American diversified forest products company based in Spokane, Washington.
MD vs PCH — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $314.2M |
| Net Profit | $33.7M | $25.9M |
| Gross Margin | — | 18.2% |
| Operating Margin | 9.9% | 11.2% |
| Net Margin | 6.8% | 8.2% |
| Revenue YoY | -1.7% | 23.1% |
| Net Profit YoY | 10.5% | 682.5% |
| EPS (diluted) | $0.40 | $0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | — | ||
| Q3 25 | $492.9M | $314.2M | ||
| Q2 25 | $468.8M | $275.0M | ||
| Q1 25 | $458.4M | $268.3M | ||
| Q4 24 | $502.4M | $258.1M | ||
| Q3 24 | $511.2M | $255.1M | ||
| Q2 24 | $504.3M | $320.7M | ||
| Q1 24 | $495.1M | $228.1M |
| Q4 25 | $33.7M | — | ||
| Q3 25 | $71.7M | $25.9M | ||
| Q2 25 | $39.3M | $7.4M | ||
| Q1 25 | $20.7M | $25.8M | ||
| Q4 24 | $30.5M | $5.2M | ||
| Q3 24 | $19.4M | $3.3M | ||
| Q2 24 | $-153.0M | $13.7M | ||
| Q1 24 | $4.0M | $-305.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | 18.2% | ||
| Q2 25 | — | 13.0% | ||
| Q1 25 | — | 17.8% | ||
| Q4 24 | — | 13.4% | ||
| Q3 24 | — | 10.8% | ||
| Q2 24 | — | 11.9% | ||
| Q1 24 | — | 7.0% |
| Q4 25 | 9.9% | — | ||
| Q3 25 | 13.8% | 11.2% | ||
| Q2 25 | 12.8% | 5.0% | ||
| Q1 25 | 7.0% | 10.3% | ||
| Q4 24 | 7.8% | 5.2% | ||
| Q3 24 | 6.6% | 2.8% | ||
| Q2 24 | -31.3% | 5.4% | ||
| Q1 24 | 3.2% | -2.1% |
| Q4 25 | 6.8% | — | ||
| Q3 25 | 14.5% | 8.2% | ||
| Q2 25 | 8.4% | 2.7% | ||
| Q1 25 | 4.5% | 9.6% | ||
| Q4 24 | 6.1% | 2.0% | ||
| Q3 24 | 3.8% | 1.3% | ||
| Q2 24 | -30.3% | 4.3% | ||
| Q1 24 | 0.8% | -0.1% |
| Q4 25 | $0.40 | — | ||
| Q3 25 | $0.84 | $0.33 | ||
| Q2 25 | $0.46 | $0.09 | ||
| Q1 25 | $0.24 | $0.33 | ||
| Q4 24 | $0.37 | $0.07 | ||
| Q3 24 | $0.23 | $0.04 | ||
| Q2 24 | $-1.84 | $0.17 | ||
| Q1 24 | $0.05 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $88.8M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $1.9B |
| Total Assets | $2.2B | $3.2B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | — | ||
| Q3 25 | $340.1M | $88.8M | ||
| Q2 25 | $224.7M | $95.3M | ||
| Q1 25 | $99.0M | $147.5M | ||
| Q4 24 | $229.9M | $151.6M | ||
| Q3 24 | $103.8M | $161.1M | ||
| Q2 24 | $19.4M | $199.7M | ||
| Q1 24 | $8.0M | $180.2M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | $1.0B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | — | ||
| Q3 25 | $890.7M | $1.9B | ||
| Q2 25 | $833.8M | $1.9B | ||
| Q1 25 | $789.2M | $2.0B | ||
| Q4 24 | $764.9M | $2.0B | ||
| Q3 24 | $732.5M | $2.1B | ||
| Q2 24 | $706.5M | $2.1B | ||
| Q1 24 | $856.2M | $2.2B |
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $3.2B | ||
| Q2 25 | $2.1B | $3.2B | ||
| Q1 25 | $2.0B | $3.3B | ||
| Q4 24 | $2.2B | $3.3B | ||
| Q3 24 | $2.1B | $3.3B | ||
| Q2 24 | $2.0B | $3.4B | ||
| Q1 24 | $2.2B | $3.4B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | 0.51× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $65.7M |
| Free Cash FlowOCF − Capex | — | $50.1M |
| FCF MarginFCF / Revenue | — | 15.9% |
| Capex IntensityCapex / Revenue | — | 4.9% |
| Cash ConversionOCF / Net Profit | 3.39× | 2.54× |
| TTM Free Cash FlowTrailing 4 quarters | — | $132.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | — | ||
| Q3 25 | $137.3M | $65.7M | ||
| Q2 25 | $137.2M | $41.0M | ||
| Q1 25 | $-117.5M | $49.1M | ||
| Q4 24 | $133.0M | $45.4M | ||
| Q3 24 | $91.8M | $26.5M | ||
| Q2 24 | $107.0M | $100.6M | ||
| Q1 24 | $-125.2M | $16.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | $50.1M | ||
| Q2 25 | — | $30.6M | ||
| Q1 25 | — | $26.3M | ||
| Q4 24 | — | $25.4M | ||
| Q3 24 | — | $-8.2M | ||
| Q2 24 | — | $72.4M | ||
| Q1 24 | — | $2.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | 15.9% | ||
| Q2 25 | — | 11.1% | ||
| Q1 25 | — | 9.8% | ||
| Q4 24 | — | 9.9% | ||
| Q3 24 | — | -3.2% | ||
| Q2 24 | — | 22.6% | ||
| Q1 24 | — | 0.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | 4.9% | ||
| Q2 25 | — | 3.8% | ||
| Q1 25 | — | 8.5% | ||
| Q4 24 | — | 7.7% | ||
| Q3 24 | — | 13.6% | ||
| Q2 24 | — | 8.8% | ||
| Q1 24 | — | 6.1% |
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | 2.54× | ||
| Q2 25 | 3.49× | 5.58× | ||
| Q1 25 | -5.66× | 1.90× | ||
| Q4 24 | 4.36× | 8.74× | ||
| Q3 24 | 4.72× | 7.99× | ||
| Q2 24 | — | 7.35× | ||
| Q1 24 | -31.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
PCH
| Lumber | $131.8M | 42% |
| Timberlands | $52.5M | 17% |
| Rural Real Estate | $51.3M | 16% |
| Residuals And Panels | $34.0M | 11% |
| Pulpwood | $16.7M | 5% |
| Development Real Estate | $14.6M | 5% |
| Other | $8.1M | 3% |
| Other Products | $5.2M | 2% |
